Insider Transactions in Q1 2024 at Y M Abs Therapeutics, Inc. (YMAB)
Insider Transaction List (Q1 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2024
|
Mary Tagliaferri Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,660
+50.0%
|
-
|
|
Mar 05
2024
|
Susan Laura Smith SVP & CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,682
-4.72%
|
$26,912
$16.55 P/Share
|
|
Mar 05
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
SELL
Open market or private sale
|
Direct |
3,900
-2.4%
|
$62,400
$16.44 P/Share
|
|
Mar 05
2024
|
Vignesh Rajah SVP & CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,711
-4.81%
|
$27,376
$16.53 P/Share
|
|
Feb 12
2024
|
Michael J Rossi PRESIDENT & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
35,700
+50.0%
|
-
|
|
Jan 18
2024
|
Susan Laura Smith SVP & CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,800
+33.33%
|
-
|
|
Jan 18
2024
|
Vignesh Rajah SVP & CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,800
+33.33%
|
-
|
|
Jan 18
2024
|
Joris Wilms SVP & CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,800
+33.33%
|
-
|
|
Jan 18
2024
|
Steen Lisby SVP & CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,800
+33.33%
|
-
|
|
Jan 18
2024
|
Thomas Gad CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
22,100
+11.97%
|
-
|
|
Jan 18
2024
|
Torben Lund Hansen SVP & CHIEF TECHNICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
17,800
+33.33%
|
-
|
|
Jan 18
2024
|
Bo Kruse EVP, CFO, SECRY & TREAS. |
BUY
Grant, award, or other acquisition
|
Direct |
18,100
+7.9%
|
-
|